Rachlin Evan Lockwoodinsider trades
In SEC Form 4 filings, Rachlin Evan Lockwood is listed as Director of Iambic Therapeutics, Inc. (IAM). In the last 90 days, Rachlin Evan Lockwood bought $11.50M of Iambic Therapeutics, Inc. (IAM) on the open market and sold none. The purchase was $11.50M of Iambic Therapeutics, Inc. (IAM) on Oct 16.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| IAMIambic Therapeutics, Inc. | Director | 9 | Oct 19 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-16
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| IAMIambic Therapeutics, Inc. | Oct 16 | Oct 19 | C | 1,458,736 | not reported | not reported | 1,458,736 | No | Form 4 |
| IAMIambic Therapeutics, Inc. | Oct 16 | Oct 19 | C | 410,762 | not reported | not reported | 1,869,498 | No | Form 4 |
| IAMIambic Therapeutics, Inc. | Oct 16 | Oct 19 | P | 718,750 | $16.00 | Purchase +$11,500,000 | 2,588,248 | No | Form 4 |
| IAMIambic Therapeutics, Inc. | Oct 16 | Oct 19 | C | 57,754 | not reported | not reported | 57,754 | No | Form 4 |
| IAMIambic Therapeutics, Inc. | Oct 16 | Oct 19 | C · derivative | 1,152,025 | $0.00 | $0 | not reported | No | Form 4 |
| IAMIambic Therapeutics, Inc. | Oct 16 | Oct 19 | C · derivative | 57,754 | $0.00 | $0 | not reported | No | Form 4 |
| IAMIambic Therapeutics, Inc. | Oct 16 | Oct 19 | C · derivative | 306,711 | $0.00 | $0 | not reported | No | Form 4 |
| IAMIambic Therapeutics, Inc. | Oct 16 | Oct 19 | C · derivative | 410,762 | $0.00 | $0 | not reported | No | Form 4 |
| IAMIambic Therapeutics, Inc. | Oct 14 | Oct 16 | A · derivative | 20,300 | $16.00 | $324,800 | 20,300 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.